Pediatrix Q4 GAAP EPS $0.29, adjusted $0.47; revenue $514M; 2023 EBITDA guidance $235-245M

Pediatrix Medical Group, Inc.

2022-FY EPS reported $0.79 revenue$1,972,021,000

Net revenue $513.8M (+3.1% YoY); same-unit patient volume +4.1%; commercial payor mix improved 20 bps.
GAAP diluted EPS $0.29 vs $0.47; Adjusted EPS $0.47 vs $0.52; CARES Act benefit declined materially.
Adjusted EBITDA $66.5M vs $81.0M; full year 2022 Adjusted EBITDA $241.0M, GAAP EPS $0.74.
2023 preliminary Adjusted EBITDA guidance $235-245M, assuming no additional CARES Act funds.
Revenue cycle management vendor underperformance partly offset by vendor support; overhead costs reduced.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Pediatrix Medical Group, Inc. reported financial results for the twelve months ended December 31, 2022.

Period: the twelve months ended December 31, 2022
Result: reported results

Exact text from the filing

On February 17, 2023, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and twelve months ended December 31, 2022 (the “Fourth Quarter Release”).

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Pediatrix Medical Group, Inc. reported financial results for the three months ended December 31, 2022.

Period: the three months ended December 31, 2022
Result: reported results

Exact text from the filing

On February 17, 2023, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and twelve months ended December 31, 2022 (the “Fourth Quarter Release”).

View on SEC.gov

Browse all earnings releases →

Pediatrix Medical Group, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-003125

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.